-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$58.0045.91% Upside
NuVasive, Inc. Frequently Asked Questions
-
What analysts cover NuVasive, Inc.?
NuVasive, Inc. has been rated by research analysts at RBC Capital, Piper Sandler, Truist Financial, J.P. Morgan, Citigroup, Canaccord Genuity in the past 90 days.